Abstract
A randomized, active-control clinical trial setting with the objective of testing noninferiority for a continuous response variable is considered. Noninferiority margin is based on the concept of preserving a certain fraction of the active control effect. Noninferiority is established if the ratio of the lower (upper) limit of the two-sided 95% confidence interval for the treatment difference to the estimated mean of the active control is greater (less) than a certain fraction. The nominal significance level is not maintained by the above confidence interval-based noninferiority test. We use bootstrapping to derive an accurate lower (upper) limit of the same confidence interval, which approximates the nominal significance level better and improves the power.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 357-363 |
| Number of pages | 7 |
| Journal | Journal of Biopharmaceutical Statistics |
| Volume | 16 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2006 |
All Science Journal Classification (ASJC) codes
- Statistics and Probability
- Pharmacology
- Pharmacology (medical)
Keywords
- Active control
- Equivalence